Basic Research
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2006; 12(12): 1912-1917
Published online Mar 28, 2006. doi: 10.3748/wjg.v12.i12.1912
Table 1 Liver fibrosis serum markers test for rats in different treatment group
Group5th wk8th wk
HA µg/LCIV µg/LHA µg/LCIV µg/L
A43 ± 1919 ± 1037 ± 1746 ± 16
Bb324 ± 92206 ± 70130 ± 52136 ± 28
Ca66 ± 20c74 ± 19c58 ± 22c57 ± 211
Table 2 Degree of fibrosis for rats in different treatment group
Group5th wk 8th wk

F0
F1
F2
F3
F4
F0
F1
F2
F3
F4
A77
Bb3416
Cad52331
Table 3 Ballooning degeneration and steatosis for rats in different treatment group
Group5th wk 8th wk

0
1
2
3
0
1
2
3
A77
Bb34124
Ca1643
Table 4 Percentage collagen content for rats in different treatment groups
Group5th wk8th wk
A00
B b5.2 ± 1.67.3 ± 1.6
C3.8 ± 0.9a4.7 ± 1.0c
Table 5 Liver function tests for rats in different treatment group
Group5th wk 8th wk

ALT U/L
AST U/L
γ-GT U/L
ALT U/L
AST U/L
γ-GT U/L
A34 ± 1299 ± 12 13 ± 732 ± 9100 ± 1915 ± 12
Ba135 ± 24158 ± 1945 ± 23133 ± 34166 ± 2874 ± 36
C43 ± 12be118 ± 10bf28 ± 19de 47 ± 10bg139 ± 13cf52 ± 21df
Table 6 Expression of PCNA and α-SMA of rats in different treatment group
Group5th wk 8th wk

PCNA
α-SMA
PCNA
α-SMA
A 17.4 ± 7.01.4 ± 0.516.6 ± 7.81.3 ± 0.5
B27.9 ± 8.3a4.9 ± 2.3b21.0 ± 5.4c4.6 ± 1.5b
Cg43.4 ± 14.0e3.7 ± 2.1131.0 ± 10.0e2.6 ± 1.0e